These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 21296345

  • 21. [Competitive employment in schizophrenia: clinical and neuropsychological correlates and quality of life].
    Birindelli N, Castagna F, Giugiario M, Graffino M, Mingrone C, Sandei L, Rocca P.
    Riv Psichiatr; 2012; 47(2):89-95. PubMed ID: 22622245
    [Abstract] [Full Text] [Related]

  • 22. Objective: remission of depression in primary care The Oreon Study.
    Ansseau M, Demyttenaere K, Heyrman J, Migeotte A, Leyman S, Mignon A.
    Eur Neuropsychopharmacol; 2009 Mar; 19(3):169-76. PubMed ID: 19144502
    [Abstract] [Full Text] [Related]

  • 23. Quality of life in bipolar type I disorder and schizophrenia in remission: clinical and neurocognitive correlates.
    Brissos S, Dias VV, Carita AI, Martinez-Arán A.
    Psychiatry Res; 2008 Jul 15; 160(1):55-62. PubMed ID: 18485488
    [Abstract] [Full Text] [Related]

  • 24. Individual quality of life of people with severe mental disorders.
    Pitkänen A, Hätönen H, Kuosmanen L, Välimäki M.
    J Psychiatr Ment Health Nurs; 2009 Feb 15; 16(1):3-9. PubMed ID: 19192080
    [Abstract] [Full Text] [Related]

  • 25. Quality of life and functioning ability in subjects vulnerable to psychosis.
    Svirskis T, Korkeila J, Heinimaa M, Huttunen J, Ilonen T, Ristkari T, Hietala J, Syvälahti E, McGlashan T, Vahlberg T, Salokangas RK.
    Compr Psychiatry; 2007 Feb 15; 48(2):155-60. PubMed ID: 17292706
    [Abstract] [Full Text] [Related]

  • 26. [The relationship between quality of life of schizophrenic patients and clinical parameters of psychosis].
    Górecka JE, Czernikiewicz A.
    Wiad Lek; 2004 Feb 15; 57(9-10):408-12. PubMed ID: 15765753
    [Abstract] [Full Text] [Related]

  • 27. Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia.
    Wehmeier PM, Kluge M, Schneider E, Schacht A, Wagner T, Schreiber W.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr 13; 31(3):703-12. PubMed ID: 17289237
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Quality of life and depression in schizophrenic patients.
    Górna K, Jaracz K, Wrzyszczyńska L, Rybakowski F.
    Adv Med Sci; 2007 Apr 13; 52 Suppl 1():108-11. PubMed ID: 18229644
    [Abstract] [Full Text] [Related]

  • 30. Effect of thought disorders on quality of life in patients with schizophrenia.
    Ulas H, Akdede BB, Ozbay D, Alptekin K.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb 15; 32(2):332-5. PubMed ID: 17854967
    [Abstract] [Full Text] [Related]

  • 31. The sensitivity of quality-of-life scale WHOQOL-100 to psychopathological measures in schizophrenia.
    Orsel S, Akdemir A, Dağ I.
    Compr Psychiatry; 2004 Feb 15; 45(1):57-61. PubMed ID: 14671738
    [Abstract] [Full Text] [Related]

  • 32. Subjective quality of life in first episode schizophrenia spectrum disorders with comorbid depression.
    Sim K, Mahendran R, Siris SG, Heckers S, Chong SA.
    Psychiatry Res; 2004 Dec 15; 129(2):141-7. PubMed ID: 15590041
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Insight and quality of life in long-term hospitalized Japanese patients with chronic schizophrenia.
    Nakamae T, Kitabayashi Y, Okamura A, Shibata K, Iwahashi S, Naka F, Morinobu M, Watanabe M, Narumoto J, Kitabayashi M, Fukui K.
    Psychiatry Clin Neurosci; 2010 Aug 15; 64(4):372-6. PubMed ID: 20546166
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. A post hoc analysis of negative symptoms and psychosocial function in patients with schizophrenia: a 40-week randomized, double-blind study of ziprasidone versus haloperidol followed by a 3-year double-blind extension trial.
    Stahl SM, Malla A, Newcomer JW, Potkin SG, Weiden PJ, Harvey PD, Loebel A, Watsky E, Siu CO, Romano S.
    J Clin Psychopharmacol; 2010 Aug 15; 30(4):425-30. PubMed ID: 20571437
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.